Live RSS
Federal Grant · National Institutes of Health

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.

BiotechHealthcare TechMaterials ScienceManufacturing small-businessstartupuniversity-researcher
The pitch

If your biotech innovation is science-ready but commercialization is the bottleneck, partner with industry and tap NIH's 5–10 year development runway.

Award range
Unspecified
Closes
Sep 7, 2027 · 496d left
Open date
Nov 6, 2024
Difficulty
High
Source
Grants.gov
Agency
National Institutes of Health
Last verified
2026-04-29
Fit language
Possible fit only
Apply at grants.gov →

Report stale or inaccurate summary

What this is

This NIH program funds collaborative R&D between universities and companies to translate promising bioengineering innovations into robust, well-characterized solutions for life sciences and medicine. The focus is on technological breakthroughs that integrate academia's research depth with industry's commercialization expertise. Small businesses, nonprofits, universities, and government entities are all eligible to apply as lead or partner organizations. The award timeline extends through September 2027, with emphasis on delivering real-world impact and scalable technologies.

Who can apply

Eligible applicants include small businesses, for-profit companies, universities (public and private), nonprofits with or without 501(c)(3) status, government entities, tribal organizations, and special districts. Academic–industry partnerships are explicitly encouraged; at least one partner should typically be from industry and one from academia.

Eligible applicant types

Full description — from the agency

This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 10 years.

Topics: bioengineering partnerships · industry collaboration · medical device development · translational research · nih funding biotech · unmet clinical needs · quantitative engineering

Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.